MultiPlan posts Q3 net loss $391.5M on $361.6M goodwill impairment; revenue down 5.1%

Claritev Corp

2024-Q3 EPS reported -$93.43 revenue$698,479,000

Revenue $230.5M (-5.1% YoY); net loss $391.5M vs loss $24.1M in Q3 2023.
Adjusted EBITDA $141.6M (down from $152.3M); Free Cash Flow $41.1M (down from $49.7M).
Recorded $361.6M impairment charge for goodwill and indefinite-lived intangibles.
Identified $6.4B potential medical cost savings in Q3, +10% YoY.
Updated FY2024 guidance: revenues $930-940M (previous $935-955M), Adj. EBITDA $580-590M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.